Trial Results: How one patient’s role in an ECOG-ACRIN study for acute lymphocytic leukemia brought a cancer-free diagnosis and FDA approval
September 26, 2024
Now Enrolling: The EA7222 clinical trial is testing a new treatment for patients with advanced soft tissue sarcoma
September 26, 2024Video: An advocate and a physician discuss the SOAR study for patients with advanced kidney cancer
Focused Radiation versus Systemic Therapy for Patients with Kidney Cancer with Limited Metastasis
Below, watch research advocate Glenn Sykes, a kidney cancer patient for 14 years, talk with SOAR study chair Dr. Raquibul Hannan about the SOAR clinical trial (EA8211). This study is currently recruiting patients. It is exploring focused radiation therapy for patients with kidney cancer that has spread beyond the kidney to a limited number of other areas (2–5) in the body. This approach may allow patients with slowly progressing cancer to live longer with a better quality of life compared to standard treatment.
Learn more about EA8211/SOAR at ecog-acrin.org.
